Drug distributor McKesson Corp. says it expects to shoulder more than $100 million in opioid-related legal expenses this year. Both McKesson and AmerisourceBergen downplayed their roles in the opioid epidemic in their respective earnings calls.
Drug distributor McKesson Corp. says it expects to shoulder more than $100 million in opioid-related legal expenses this year. Both McKesson and AmerisourceBergen downplayed their roles in the opioid epidemic in their respective earnings calls.